meturedepa (AB 132)

structure in Merck Index, 9th ed, #6031

Also Known As:

AB 132; NSC 51325; ethyl (bis(2,2-dimethyl-1-aziridinyl)phosphinyl)carbamate; (bis(2,2-dimethyl-1-aziridinyl)phosphinyl)carbamic acid, ethyl ester

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azirines
    - Aziridines: 14
      - meturedepa: 3

Related Diseases

1.	Bronchogenic Carcinoma 07/01/1964 - "COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA." 01/01/1980 - "Patients with bronchogenic carcinoma or with advanced pediatric solid tumours were treated with various radiation therapy schedules alone or with a new alkylating carbamate: AB 132. "
2.	Neoplasms (Cancer) 10/01/1968 - "Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. "

Related Drugs and Biologics

1.	Carbamates

Related Therapies and Procedures

1.	Radiotherapy